NCT06038201

Brief Summary

In this new era of less invasive procedures, the indications for endoscopic ultrasound (EUS)-guided gallbladder drainage (GBD) are rapidly expanding. Nowadays, the standard treatment for uncomplicated cholelithiasis (symptomatic patients not requiring hospital admission or non-surgically managed during one or more hospital admissions) is elective laparoscopic cholecystectomy. To avoid the complications, difficulties and disadvantages of cholecystectomy, the investigators proposed a single-center study to determine the safety and effectiveness of EUS-guided GBD with electrocautery-enhanced lumen-apposing metal stent (LAMS) (Boston Scientific, Marlborough, MA, EEUU) with stone removal in patients with cholelithiasis, in comparison with the gold standard treatment, the elective laparoscopic cholecystectomy.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
56

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Oct 2023

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 30, 2023

Completed
15 days until next milestone

First Posted

Study publicly available on registry

September 14, 2023

Completed
1 month until next milestone

Study Start

First participant enrolled

October 25, 2023

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 2, 2024

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

November 2, 2024

Completed
Last Updated

March 29, 2024

Status Verified

March 1, 2024

Enrollment Period

11 months

First QC Date

August 30, 2023

Last Update Submit

March 28, 2024

Conditions

Keywords

Cholelithiasisbiliarycholecystostomylaparoscopiccholecystectomygallstones

Outcome Measures

Primary Outcomes (4)

  • Technical success after surgical and endoscopic intervention

    Number of patients with correct placement LAMS or uneventful competition of laparoscopic cholecystectomy along with stone clearance.

    Up to 6 hours

  • Resolution of biliary symptoms

    Number of patients with clinical resolution based in a questionnaire for the assessment of biliary symptoms.

    up to 12 months

  • Adverse events after the surgical procedures

    The post-surgical adverse events will be assessed by the Clavien-Dindo classification

    up to 14 days

  • Adverse events after the endoscopic procedures

    The post-endoscopic adverse events will be assessed by the Adverse Events Gastrointestinal Endoscopy (AGREE) Classification

    Up to 14 days

Secondary Outcomes (2)

  • 30-day major complications assessment

    up to 30 days

  • Re-intervention rate

    12-month follow-up

Study Arms (2)

EUS-GBD with stone clearance

EXPERIMENTAL

Patients \>18-year-old with a diagnosis of gallstones by abdominal ultrasound, will be randomly allocated to EUS-guided GBD with electrocautery-enhanced lumen-apposing metal stent (LAMS) (Boston Scientific, Marlborough, MA, EEUU) with stone clearance.

Procedure: LAMS placement for cholecystostomy

Elective laparoscopic cholecystectomy

ACTIVE COMPARATOR

Patients \>18-year-old with a diagnosis of gallstones by abdominal ultrasound are randomly allocated to elective laparoscopic cholecystectomy and laparoscopic biliary exploration.

Procedure: Laparoscopic cholecystectomy

Interventions

The EUS-guided cholecystostomy entails placing a 10 mm x 10 mm or 10mm x 15mm Electrocautery-Enhanced LAMS for direct cholecystoscopy with a transnasal gastroscope. Then, the cholecystostomy will be performed with an echoendoscope, assisted by fluoroscopy to allow the puncturing of the gallbladder form either the duodenal bulb (cholecysto-duodenoscopy) or the gastric antrum (cholecysto-gastrostomy). Subsequently, from the most optimal anatomic point it will be tutored with a 10mmx10mm or 10mm x 15mm LAMS to create anastomosis between the structures. Then, the stone clearance will be performed by endoscopy (basket catheters) or by cholangioscopy (mechanical lithotripsy with or without basket catheters).

EUS-GBD with stone clearance

A laparoscopic biliary exploration along with an elective laparoscopic cholecystectomy will be performed by experienced laparoscopic surgeons (over 100 laparoscopic procedures yearly) by three or four-trocar technique with transection of the cystic duct and artery.

Elective laparoscopic cholecystectomy

Eligibility Criteria

Age18 Years - 89 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adults \>18 years old and \<89 years old
  • Adult symptomatic patients with gallstones documented by US
  • Subject is a suitable candidate for an elective laparoscopic cholecystectomy or an EUS-guided GBD
  • Patients or authorized representative give informed consent for endoscopic or surgical approach

You may not qualify if:

  • Patients with hepato-pancreato-biliary diseases other than gallstones (tumors, obstructions, inflammation)
  • Patients with acute cholecystitis, cholangitis or choledocholithiasis.
  • Patients with gallbladder polyps, family history of gallbladder cancer, or any other high-risk factor for gallbladder cancer
  • Patient unable to give informed consent or refuse to participate.
  • Prior biliary intervention
  • Pregnancy or nursing
  • Any other medical condition that contraindicates surgical or endoscopic procedures

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Instituto Ecuatoriano de Enfermedades Digestivas

Guayaquil, Guayas, 090505, Ecuador

RECRUITING

Related Publications (5)

  • Kamarajah SK, Karri S, Bundred JR, Evans RPT, Lin A, Kew T, Ekeozor C, Powell SL, Singh P, Griffiths EA. Perioperative outcomes after laparoscopic cholecystectomy in elderly patients: a systematic review and meta-analysis. Surg Endosc. 2020 Nov;34(11):4727-4740. doi: 10.1007/s00464-020-07805-z. Epub 2020 Jul 13.

    PMID: 32661706BACKGROUND
  • Radlinski MJ, Strand DS, Shami VM. Evolution of interventional endoscopic ultrasound. Gastroenterol Rep (Oxf). 2023 Jun 30;11:goad038. doi: 10.1093/gastro/goad038. eCollection 2023.

    PMID: 37398926BACKGROUND
  • Radunovic M, Lazovic R, Popovic N, Magdelinic M, Bulajic M, Radunovic L, Vukovic M, Radunovic M. Complications of Laparoscopic Cholecystectomy: Our Experience from a Retrospective Analysis. Open Access Maced J Med Sci. 2016 Dec 15;4(4):641-646. doi: 10.3889/oamjms.2016.128. Epub 2016 Nov 9.

    PMID: 28028405BACKGROUND
  • Du QC, Wang YY, Hu CL, Zhou Y. Reconsideration of indications for choledochoscopic gallbladder-preserving surgery and preventive measures for postoperative recurrence of gallstones. Wideochir Inne Tech Maloinwazyjne. 2020 Mar;15(1):87-96. doi: 10.5114/wiitm.2019.88647. Epub 2019 Oct 17.

    PMID: 32117490BACKGROUND
  • Flynn DJ, Memel Z, Hernandez-Barco Y, Visrodia KH, Casey BW, Krishnan K. Outcomes of EUS-guided transluminal gallbladder drainage in patients without cholecystitis. Endosc Ultrasound. 2021 Sep-Oct;10(5):381-386. doi: 10.4103/EUS-D-21-00040.

    PMID: 34677160BACKGROUND

MeSH Terms

Conditions

CholelithiasisGallstones

Interventions

CholecystostomyCholecystectomy, Laparoscopic

Condition Hierarchy (Ancestors)

Biliary Tract DiseasesDigestive System DiseasesCholecystolithiasisGallbladder DiseasesCalculiPathological Conditions, AnatomicalPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Anastomosis, SurgicalSurgical Procedures, OperativeBiliary Tract Surgical ProceduresDigestive System Surgical ProceduresCholecystectomyLaparoscopyEndoscopyMinimally Invasive Surgical Procedures

Study Officials

  • Carlos Robles-Medranda, MD, FASGE

    Instituto Ecuatoriano de Enfermedades Digestivas

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Carlos Robles-Medranda, MD, FASGE

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
SINGLE
Who Masked
INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: A controlled, non-inferiority prospective trial
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Head of Endoscopy Division

Study Record Dates

First Submitted

August 30, 2023

First Posted

September 14, 2023

Study Start

October 25, 2023

Primary Completion

October 2, 2024

Study Completion

November 2, 2024

Last Updated

March 29, 2024

Record last verified: 2024-03

Data Sharing

IPD Sharing
Will not share

Locations